| Literature DB >> 22952590 |
Walter R Taylor1, Kinh Nguyen, Duc Nguyen, Huyen Nguyen, Peter Horby, Ha L Nguyen, Trinh Lien, Giang Tran, Ninh Tran, Ha M Nguyen, Thai Nguyen, Ha H Nguyen, Thanh Nguyen, Giap Tran, Jeremy Farrar, Menno de Jong, Constance Schultsz, Huong Tran, Diep Nguyen, Bich Vu, Hoa Le, Trinh Dao, Trung Nguyen, Heiman Wertheim.
Abstract
OBJECTIVES: To determine prospectively the causative pathogens of central nervous system (CNS) infections in patients admitted to a tertiary referral hospital in Hanoi, Vietnam.Entities:
Mesh:
Year: 2012 PMID: 22952590 PMCID: PMC3431395 DOI: 10.1371/journal.pone.0042099
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient demographic, clinical and laboratory features diagnosed with confirmed or clinically suspected bacterial meningitis, tuberculous meningitis and aseptic encephalitis/meningitis.
| Bacterial meningitis | P | Tuberculous meningitis | P | Aseptic encephalitis meningitis | P | ||||
| confirmed n = 62 | Suspected n = 51 | confirmed n = 9 | suspected n = 58 | confirmed n = 19 | suspected n = 54 | ||||
|
| |||||||||
| Age | 46 (17–78) | 40 (14–76) | 0.34 | 36 (15–69) | 34 (14–76) | 0.6 | 30 (17–85) | 26 (13–75) | 0.052 |
| F∶M | 10∶52 | 18∶33 | 0.019 | 4∶5 | 19∶39 | 0.49 | 7∶12 | 29 25 | 0.2 |
| HIV positive by history | 0/58 (0) | 2 (3.9) | 0.12 | 3/8 (37.5) | 13 (22.4) | 0.35 | 0/16 (0) | 2 (3.7) | 0.43 |
| Referred by another hospital | 49/58 (84.5) | 44 (86.2) | 0.79 | 5/8 (62.5) | 43 (74.1) | 0.48 | 12/16 (75) | 43 (79.6) | 0.69 |
| Preadmission antibiotic use | 39/58 (67.2) | 44 (86.3) | 0.02 | 5/8 (62.5) | 40 (68.9) | 0.71 | 11/16 (68.75) | 36 (66.7) | 0.87 |
| Length of illness | 3.5 (0–17) | 6.5 (1–31) | 0.34 | 12.5 (1–31) | 15.5 (2–61) | 0.61 | 7 (0–22) | 6 (1–31) | 0.051 |
|
| |||||||||
| Fever | 58/58 (100) | 50 (98.1) | 0.28 | 7/8 (87.5) | 57 (98.3) | 0.096 | 16/16 (100) | 51 (94.4) | 0.33 |
| Headache | 54/58 (93.1) | 51 (100) | 0.056 | 8/8 (100) | 58 (100) | - | 14/16 (87.5) | 52 (96.3) | 0.18 |
| Vomiting | 45 (77.6) | 43 (84.3) | 0.37 | 5/8 (62.5) | 39 (67.2) | 0.79 | 8/16 (50) | 34 (62.9) | 0.35 |
| Convulsions | 5/58 (8.6) | 6 (11.7) | 0.58 | 0 (0) | 4 (6.9) | 0.4 | 5/16 (31.25) | 17 (31.5) | 0.98 |
|
| |||||||||
| Temperature °C | 38.5 (36.4–40) | 38 (36–39.8) | 0.003 | 37.2 (36.2–38) | 37.8 (36–39.9) | 0.054 | 38.4 (37–39.8) | 38.2 (36.5–40.5) | 0.73 |
| GCS | 13 (6–15) | 15 (5–15) | 0.006 | 14 (11–15) | 15 (6–15) | 0.54 | 13 (5–15) | 13 (4–15) | 0.56 |
| GCS = 15 | 18/57 (31.6) | 28/49 (57.1) | 0.008 | 3/8 (37.5) | 32 (55.2) | 0.34 | 7/16 (43.75) | 15/54 (27.8) | 0.22 |
| Stiff neck | 55 (94.8) | 41 (80.4) | 0.02 | 8 (100) | 48 (82.7) | 0.2 | 14 (87.5) | 42 (77.8) | 0.39 |
| Kernig's sign | 50 (86.2) | 28 (54.9) | 0.00 | 6 (75) | 40 (68.9) | 0.72 | 8 (50) | 35 (64.8) | 0.28 |
| Skin rash | 6/58 (10.3) | 5/51 (9.8) | 0.9 | 0 (0) | 2 (3.45) | 0.59 | 1/16 (6.25) | 3/54 (5.6) | 0.9 |
|
| |||||||||
| Haemoglobin g/dL | 12.9 (8.5–15.7) | 12.6 (8.7–16.6) | 0.32 | 11.3 (10–13) | 12.4 (3.75–16.7) | 0.17 | 12.7 (10.1–15.6) | 13 (5.6–17.9) | 0.9 |
| Total white cell count/µL | 15.5 (6.28–36.2) | 12.3 (3.27–29.36) | 0.0001 | 9.3 (2–16) | 9.13 (1.73–28.8) | 0.91 | 9.96 (5.6–23.7) | 10 (3.5–25.9) | 0.77 |
| Leukocytosis >11000/µL | 51/60 (85) | 29 (56.8) | 0.001 | 4 (44.4) | 19 (32.7) | 0.49 | 4/17 (23.5) | 23 (42.6) | 0.15 |
| Relative neutrophilia >75% | 54/59 (81.3) | 26/50 (52) | 0.000 | 9 (100) | 34/57 (59.6) | 0.018 | 10/16 (62.5) | 31/52 (59.6) | 0.83 |
| Platelet count/µL | 126 (4–770) | 236 (21–490) | 0.000 | 250 (112–587) | 248 (72–456) | 0.78 | 209 (4.51–369) | 208 (54–628) | 0.88 |
|
| |||||||||
| Illness duration at LP | 4 (0–17) | 7 (1–31) | 0.0007 | 12.5 (1–31) | 15.5 (3–61) | 0.29 | 7.5 (0–22) | 6 (1–32) | 0.45 |
| Cloudy | 45/55 (81.8) | 19/48 (39.6) | 0.000 | 6/8 (75) | 17/54 (31.5) | 0.017 | 4/16 (25) | 12/53 (22.64) | 0.84 |
| Opening pressure cm CSF | 27 (6–40) | 20 (7–40) | 0.037 | 20 (7.5–37) | 26.25 (5–40) | 0.47 | 17.25 (7–29) | 11.5 (5–40) | 0.8 |
| Opening pressure >20 cm CSF | 21/29 (72.4) | 17/36 (47.2) | 0.04 | 3/6 (50) | 22/34 (64.7) | 0.49 | 2/8 (25) | 10/37 (27.1) | 0.9 |
| Total white cell count/mm3 | 1750 (10–34,000) | 195 (10–42,900) | 0.000 | 391 (67–4300) | 215 (8–1300) | 0.2 | 115 (5–600) | 54 (2–770) | 0.06 |
| % >50% neutrophilia | 49/59 (83.1) | 19/46 (41.3) | 0.000 | 4/9 (44.4) | 10/53 (18.8) | 0.09 | 1/16 (6.25) | 3/36 (8.3) | 0.79 |
| Glucose mmol/L | 1.1 (0.05–4.8) | 2.6 (0.4–6.6) | 0.000 | 1.2 (0.5–2.7) | 1.9 (0.2–8.2) | 0.05 | 3.3 (1.2–5.8) | 3.45 (1.76–6.6) | 0.89 |
| CSF∶blood glucose ratio | 0.17 (0.009–1.1) | 0.4 (0.059–1.06) | 0.000 | 0.21 (0.08–0.41) | 0.29 (0.075–1) | 0.01 | 0.5 (0.19–0.92) | 0.53 (0.21–0.8) | 0.72 |
| CSF∶blood ratio <50% | 38/45 (84.4) | 32/41 (78.05) | 0.44 | 7/7 (100) | 37/47 (78.7) | 0.18 | 6/14 (42.8) | 16/38 (42.1) | 0.96 |
| Total protein g/L | 1.85 (0.56–7.5) | 0.82 (0.33–3.75) | 0.000 | 1.6 (0.5–2.3) | 1.4 (0.39–11.8) | 0.61 | 1.25 (0.2–4.2) | 0.7 (0.13–2.4) | 0.27 |
All continuous data are median (range).
Selected patient characteristics when confirmed and clinically suspected diagnoses are combined.
| Bacterial meningitis n = 113 | Tuberculous meningitis n = 67 | Aseptic encephalitis meningitis n = 73 | P for 3 group comparisons | |
|
| ||||
| Convulsions | 11/109 (10.1) | 4/66 (6.1) | 22/70 (31.4) | 0.000 |
|
| ||||
| Total white cell count ×1000/µL | 13.9 (3.27–36.2) | 9.17 (1.73–28.8) | 9.96 (3.3–29.96) | 0.0001 |
| Leukocytosis >11,000/µL | 80/111 (72.1) | 23/67 (34.3) | 27/71 (38.03) | 0.000 |
| Neutrophilia ≥75% | 80/109 (73.4) | 43/66 (65.1) | 41/68 (60.3) | 0.17 |
|
| ||||
| Cloudy | 64/103 (62.1) | 23/62 (37.1) | 16/69 (23.2) | 0.000 |
| Opening pressure cm CSF | 24 (6–40) n = 65 | 25 (5–40) n = 40 | 17 (5–40) n = 45 | 0.00048 |
| Opening pressure >20 cm CSF | 38/65 (58.4%) | 25/40 (62.5%) | 12/45 (26.6) | 0.001 |
| Total white cell count/µL | 500 (10–42,900) | 220 (8–4300) | 63 (2–770) | 0.0001 |
| % >50% neutrophilia | 68/105 (64.8) | 14/62 (22.6%) | 4/52 (7.7) | 0.000 |
| CSF∶blood glucose ratio | 0.27 (0.009–1.1) | 0.27 (0.075–1) | 0.52 (0.19–0.92) | 0.00018 |
| CSF∶blood glucose ratio <50% | 70/86 (81.4) | 44/54 (81.4) | 22/52 (42.3) | 0.000 |
| Total protein g/L | 1.39 (0.33–7.5) | 1.4 (0.39–11.8) | 0.7 (0.13–4.2) | 0.0001 |
All continuous data are median (range).
AEM vs. TBM & AEM vs. BM, ps≤0.000.
BM vs. TBM & BM vs. AEM, ps = 0.000.
BM vs. TBM p = 0.002, BM vs. AEM, p = 0.000.
AEM vs. BM & TBM, ps 0.001.
AEM vs. BM & TBM, ps<0.000, TBM vs. AEM, p = 0.018.
Figure 1Profile of patient numbers with confirmed and clinically diagnosed meningitis or encephalitis.
Pathogens isolated or detected by routine culture and or molecular methods.
| Total N confirmed | Blood culture positive | CSF culture positive | PCR positive | Molecular alone | 16S RNA | Blood culture alone | CSF culture alone | Blood & CSF culture & PCR positive | CSF culture & PCR positive | Mixed results | |
|
| 48 | 10 | 27 | 43 | 19 (39.6) | 0 | 1 | 3 | 7 | 16 | 2 |
|
| 7 | 1 | 3 | 6 | 3 (42.9) | 1 | 0 | 0 | 4 | 0 | NA |
|
| 2 | 0 | 0 | 2 | 2 (100) | 0 | 0 | 0 | 0 | 0 | NA |
|
| 1 | 0 | 0 | NA | 1 (100) | 1 | 0 | 0 | 0 | 0 | NA |
|
| 1 | 0 | 0 | NA | 1 (100) | 1 | 0 | 0 | 0 | 0 | NA |
|
| 1 | 0 | 0 | NA | 1 (100) | 1 | 0 | 0 | 0 | 0 | NA |
|
| 1 | 1 | 0 | NA | 0 | 0 | 1 | 0 | 0 | 0 | NA |
| Streptococcus species | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | NA |
|
| 12 | NA | NA | 12 | 12 (100) | NA | NA | NA | NA | NA | NA |
| Enterovirus (generic) | 2 | NA | NA | 2 | 2 (100) | NA | NA | NA | NA | NA | NA |
| Varicella zoster virus | 5 | NA | NA | 5 | 5 (100) | NA | NA | NA | NA | NA | NA |
|
| 9 | NA | 4 | 5 | 3 (33.3) | NA | NA | 4 | NA | 2 | NA |
PCR or 16S rRNA. Proportion of total confirmed diagnoses due to molecular detection.
blood culture & PCR positive, blood & CSF culture positive, PCR not done.
Patient outcomes.
| Bacterial meningitis | P | Tuberculous meningitis | P | Aseptic encephalitis/meningitis | P | ||||
| confirmed n = 57 | suspected n = 51 | Confirmed n = 9 | suspected n = 58 | confirmed n = 16 | suspected n = 53 | ||||
| Inpatients days | 15.5 (2–48) | 14.5 (3–44) | 0.29 | 27.5 (7–42) | 14 (0–69) | 0.018 | 14.5 (4–59) | 11 (0–39) | 0.34 |
| Modified Rankin score | |||||||||
| 0 | 46 (80.7) | 44 (86.3) | 0.53 | 7 (87.5) | 43 (74.1) | 0.9 | 8 (50) | 35 (66.1) | 0.45 |
| 1 | 6 (10.5) | 2 (3.9) | 0 (0) | 2 (3.45) | 1 (6.25) | 4 (7.5) | |||
| 2 | 0 (0) | 2 (3.9) | 0 (0) | 1 (1.7) | 0 (0) | 2 (3.8) | |||
| 3 | 1 (1.75) | 0 (0) | 0 (0) | 0 (0) | 1 (6.25) | 0 (0) | |||
| 4 | 1 (1.75) | 1 (1.9) | 0 (0) | 3 (5.2) | 2 (12.5) | 3 (5.7) | |||
| 5 | 1 (1.75) | 1 (1.9) | 0 (0) | 0 (0) | 2 (12.5) | 4 (7.5) | |||
| 6 (Died) | 2 (3.5) | 1 (1.9) | 1 (12.5) | 9 (15.5) | 2 (12.5) | 5 (9.4) | |||
median (range) days for all patients.
p value for cross tabulation of all MRS categories.